Literature DB >> 9672133

Removal of inhibitors of CSF-PCR to improve diagnosis of herpesviral encephalitis.

V M Ratnamohan1, A L Cunningham, W D Rawlinson.   

Abstract

CSF-PCR is currently the most sensitive test to diagnose encephalitis due to cytomegalovirus or herpes simplex virus. However, false negative results sometimes arise due to inhibitors in CSF. We have shown that the inhibitory effects may be due to increased levels of proteins and increased cell numbers, but are not due to cellular DNA. Simple techniques were used to remove the inhibitors and successfully apply these methods to CSF specimens that gave equivocal results when tested untreated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672133     DOI: 10.1016/s0166-0934(98)00020-2

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  11 in total

1.  Removal of PCR inhibitors by silica membranes: evaluating the Amplicor Mycobacterium tuberculosis kit.

Authors:  B Böddinghaus; T A Wichelhaus; V Brade; T Bittner
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Use of PCR with universal primers and restriction endonuclease digestions for detection and identification of common bacterial pathogens in cerebrospinal fluid.

Authors:  J J Lu; C L Perng; S Y Lee; C C Wan
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  DNA and RNA profiling of excavated human remains with varying postmortem intervals.

Authors:  M van den Berge; D Wiskerke; R R R Gerretsen; J Tabak; T Sijen
Journal:  Int J Legal Med       Date:  2016-09-14       Impact factor: 2.686

4.  Laboratory diagnosis of common herpesvirus infections of the central nervous system by a multiplex PCR assay.

Authors:  P Markoulatos; A Georgopoulou; N Siafakas; E Plakokefalos; G Tzanakaki; J Kourea-Kremastinou
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Comparative evaluation of early diagnosis of tuberculous meningitis by different assays.

Authors:  Chao Quan; Chuan-Zhen Lu; Jian Qiao; Bao-Guo Xiao; X Li
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

6.  Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine.

Authors:  M I Allen; J Gauthier; M DesLauriers; E J Bourne; K M Carrick; F Baldanti; L L Ross; M W Lutz; L D Condreay
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

7.  Diagnostic accuracy of two multiplex real-time polymerase chain reaction assays for the diagnosis of meningitis in children in a resource-limited setting.

Authors:  Jermaine Khumalo; Mark Nicol; Diana Hardie; Rudzani Muloiwa; Phindile Mteshana; Colleen Bamford
Journal:  PLoS One       Date:  2017-03-27       Impact factor: 3.240

8.  Evaluation of the Luminex ARIES HSV 1&2 Assay and Comparison with the FTD Neuro 9 and In-house Real-Time PCR Assays for Detecting Herpes Simplex Viruses.

Authors:  Chun Kiat Lee; Chean Nee Chai; Sharah Mae Capinpin; Alynn Ang; Sau Yoke Ng; Peak Ling Lee; Christopher Wai Siong Ng; Gabriel Yan; Hong Kai Lee; Lily Lily Chiu; Roland Jureen; Benedict Yan; Tze Ping Loh
Journal:  Ann Lab Med       Date:  2018-09       Impact factor: 3.464

9.  Identification of serotype in culture negative pneumococcal meningitis using sequential multiplex PCR: implication for surveillance and vaccine design.

Authors:  Samir K Saha; Gary L Darmstadt; Abdullah H Baqui; Belal Hossain; Maksuda Islam; Dona Foster; Hassan Al-Emran; Aliya Naheed; Shams El Arifeen; Stephen P Luby; Mathuram Santosham; Derrick Crook
Journal:  PLoS One       Date:  2008-10-31       Impact factor: 3.240

10.  Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study.

Authors:  Vinod B Patel; Grant Theron; Laura Lenders; Brian Matinyena; Cathy Connolly; Ravesh Singh; Yacoob Coovadia; Thumbi Ndung'u; Keertan Dheda
Journal:  PLoS Med       Date:  2013-10-22       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.